Phase I and Pharmacologic Study of the Novel Indoloquinone Bioreductive Alkylating Cytotoxic Drug E09-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I and Pharmacologic Study of the Novel Indoloquinone Bioreductive Alkylating Cytotoxic Drug E09

Published:1994-06-15 Issue:12 Volume:86 Page:906-912
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Schellens J. H. M.,Planting A. S. Th.,van Acker B. A.C.,Loos W. J.,Boer-Dennert M. d.,van der Burg M. E.L.,Koier I.,Krediet R. T.,Stoter G.,Verweij J.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/86/12/906/7807871/86-12-906.pdf

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: Horizon scanning;Frontiers in Surgery;2022-07-26

2. Apaziquone for Nonmuscle Invasive Bladder Cancer;Urologic Clinics of North America;2020-02

3. Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis;British Journal of Cancer;2018-10

4. The efficacy of Apaziquone in the treatment of bladder cancer;Expert Opinion on Pharmacotherapy;2017-10-20

5. Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome;JNCI: Journal of the National Cancer Institute;2017-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP